Nephrology

Intensive Control of Hypertension in Nephropathic Patients

In the AASK (African-American Study of Kidney Disease and Hypertension) trial, 1094 non-diabetic, black patients, with hypertension-related nephropathy, have been examined, randomizing them to a standard or intensive anti-hypertension treatment. In spite of the average pressure value obtained through intensive treatment (130/78 vs. 141/86 mmHg), the obtained composed outcome– a reduction of 50% in glomerular filtration, terminal-stage renal disease, death – has been reached with a similar frequency in the two groups.
Read more

 http://mn.medsurfnews.com/contents/en/6208/display/intensive...

MedNews